U.S. Dermatology Partners

U. S. Dermatology Partners is a healthcare provider focused on delivering comprehensive dermatological care, including skin cancer treatment and cosmetic procedures, across various locations in the United States. Founded in 2012 and headquartered in Dallas, US, U.

S. Dermatology Partners specializes in dermatological services. The company has engaged in 4 deals to date, with the latest being a Secondary Buyout that raised USD 300. 00 mn.

The company has not undergone any notable pivots or structural changes since its inception. Gurpal Singh serves as the CEO, guiding the firm’s operations and strategic direction. U. S.

Dermatology Partners delivers comprehensive dermatological care that includes skin cancer treatment, annual skin examinations, acne management, and cosmetic procedures such as Botox and chemical peels. With over 100 locations across states like Arizona, Colorado, Kansas, Maryland, Missouri, Oklahoma, Texas, and Virginia, the company focuses on early detection of skin cancer and personalized acne treatment plans to cater to diverse patient demographics. Revenue for U. S.

Dermatology Partners is primarily generated through a fee-for-service model, with patients scheduling appointments for consultations and treatments. In the most recent year, the company reported an EBITDA of USD 20. 00 mn. Additionally, revenue is supported by a range of skincare products available online, including the MD Skin Essentials line, addressing various skin health needs across its extensive footprint.

U. S. Dermatology Partners plans to utilize recent funding from the USD 300. 00 mn Secondary Buyout to enhance its service offerings and expand into new markets.

There are intentions to introduce new products in the coming months, along with targeted expansions into additional states to broaden service accessibility, although specific geographic regions have yet to be disclosed. This strategic growth is aimed at enhancing patient care and increasing market presence.